Login

E-mail

Password

Register now

Recorded sessions

Pharmacotherapy of relapsed metastatic testicular cancer CME accredited

GR113 - 02 September 2010 - 18:15-19:00 CET

Expert: Lawrence Einhorn, Mel and Bren Simon Cancer Center, Indiana University, Indianapolis, USA
Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland
Topics: Genito-urinary cancers  

View details


Male breast cancer CME accredited

GR112 - 26 August 2010 - 18:15-19:00 CET

Expert: Sharon H. Giordano, M.D. Anderson Cancer Center, Houston, TX, USA
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer  

View details


Breast cancer chemoprevention: What is new? CME accredited

GR111 - 19 August 2010 - 18:15-19:00 CET

Expert: Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, London, UK
Discussant: Patrick Neven, University Hospitals Leuven, Leuven, Belgium
Topics: Breast cancer   Chemoprevention  

View details


Permanent implant prostate brachytherapy: The state-of-the-art CME accredited

GR110 - 12 August 2010 - 18:15-19:00 CET

Expert: Jean-Marc Cosset, Institut Curie, Paris, France
Discussant: Jesper Grau Eriksen, Odense University Hospital, Odense, Denmark
Topics: Genito-urinary cancers   Radiation oncology  

View details


The challenge of ovarian cancer in relapse CME accredited

GR109 - 05 August 2010 - 18:15-19:00 CET

Expert: Eric Pujade-Lauraine, Hospital Hotel-Dieu, Paris, France
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: Gynecological cancers  

View details


Neoadjuvant treatments in genito-urinary oncology CME accredited

GR108 - 29 July 2010 - 18:15-19:00 CET

Expert: Andrea Necchi, IRCCS Foundation, National Cancer Institute, Milano, Italy
Discussant: Nicola Nicolai, IRCCS Foundation, National Cancer Institute, Milano, Italy
Topics: Genito-urinary cancers  

View details


Management of polycythemia vera, essential thrombocythemia and myelofibrosis CME accredited

GR107 - 22 July 2010 - 18:15-19:00 CET

Expert: Ayalew Tefferi, Mayo Clinic, Rochester, MN , USA
Discussant: Luciano Wannesson, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: Haemato-oncology  

View details


Primary HPV screening for cervical cancer prevention: Results from European trials (Review article published in Nature Reviews Clinical Oncology) CME accredited

GR106 - 15 July 2010 - 18:15-19:00 CET

Expert: Elsebeth Lynge, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark
Discussant: Mario Giovanni Sideri, European Institute of Oncology, Milano, Italy
Topics: Gynecological cancers   Prevention  

View details


Recent developments in the field of cancer stem cells CME accredited

GR105 - 08 July 2010 - 18:15-19:00 CET

Expert: Malcolm R. Alison, Barts and the London School of Medicine and Dentistry - Institute of Cell and Molecular Science, London, United Kingdom
Discussant: Linda Nicholson, King's College London School of Medicine, Guy's Medical School, London, United Kingdom
Topics: Cancer stem cells  

View details


Surgical challenges in breast cancer after neo-adjuvant systemic treatment CME accredited

GR104 - 01 July 2010 - 18:15-19:00 CET

Expert: Emiel J.Th. Rutgers, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Discussant: Isabel T. Rubio, Breast Cancer Center, Hospital Universitario Vall d'Hebron, Barcelona, Spain
Topics: Breast cancer   Surgical oncology  

View details


Management of metastatic pancreatic cancer CME accredited

GR103 - 24 June 2010 - 18:15-19:00 CET

Expert: Malcolm Moore, Princess Margaret Hospital, Toronto, Canada
Discussant: Jean-Luc Van Laethem, Erasme University Hospital, Brussels, Belgium
Topics: Gastro-intestinal tumors  

View details


How to manage a case of a rare cancer CME accredited

GR102 - 17 June 2010 - 18:15-19:00 CET

Expert: Jean-Pierre Droz, Centre Leon-Berard, Lyon, France
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Rare tumors  

View details


Cancer of unknown primary: A diagnostic and therapeutic dilemma CME accredited

GR101 - 10 June 2010 - 18:15-19:00 CET

Expert: Nicholas Pavlidis, University of Ioannina, Ioannina, Greece
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Cancer of unknown primary  

View details


Role of PET in lymphoma CME accredited

GR100 - 03 June 2010 - 18:15-19:00 CET

Expert: T. Andrew Lister, St. Bartholomew's Hospital, London, United Kingdom
Discussant: Andrea Gallamini, S. Croce e Carle Hospital, Cuneo, Italy
Topics: Haemato-oncology  

View details


Chapters of Supportive Care: MASCC-ESMO antiemetic guidelines and revised EORTC G-CSF usage guidelines CME accredited

GR99 - 27 May 2010 - 18:15-19:00 CET

Expert: Matti Aapro, IMO Clinique de Genolier, Genolier, Switzerland
Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland
Topics: Side effects   Supportive care  

View details


Breast cancer: Can neoadjuvant chemotherapy be tailored? CME accredited

GR98 - 20 May 2010 - 18:15-19:00 CET

Expert: Gunter von Minckwitz, German Breast Cancer Group, Neu-Isenburg, Germany
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer  

View details


What can be done to increase the sphincter preservation rate in rectal cancer? CME accredited

GR97 - 13 May 2010 - 18:15-19:00 CET

Expert: David Sebag-Montefiore, Leeds Cancer Centre, Cookridge Hospital, Leeds, United Kingdom
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details


Debate on aggressive lymphoma: R-CHOP 21 vs 14 (based on the new data at ASH) CME accredited

GR96 - 06 May 2010 - 18:15-19:00 CET

Expert: Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre-Benite, France
Expert: Michael Pfreundschuh, University of Saarlandes , Homburg, Germany
Discussant: Luciano Wannesson, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: Haemato-oncology  

View details


Neurological side-effects caused by recently approved cancer chemotherapy drugs (Review Article published in Nature Reviews Clinical Oncology) CME accredited

GR95 - 29 April 2010 - 18:15-19:00 CET

Expert: David Schiff, Neuro-Oncology Center, University of Virginia Health System, Charlottesville, VA, USA
Discussant: Andreas Hottinger, Geneva University Hospital, Geneva, Switzerland
Topics: Side effects  

View details


Observation as an alternative in the management of renal masses CME accredited

GR94 - 22 April 2010 - 18:15-19:00 CET

Expert: Alessandro Volpe, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy
Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland
Topics: Genito-urinary cancers  

View details


How to optimize the sequence and duration of treatment for metastatic colorectal cancer? CME accredited

GR93 - 15 April 2010 - 18:15-19:00 CET

Expert: Axel Grothey, Mayo Clinic, Rochester, MN, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details


Multiple-myeloma: Is autologous transplantation still standard in younger patients? CME accredited

GR92 - 08 April 2010 - 18:15-19:00 CET

Expert: Jean-Luc Harousseau, Rene Gauducheau Cancer Center, Nantes, France
Discussant: Luciano Wannesson, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: Haemato-oncology  

View details


GEJ and gastric cancers: Treatment overview CME accredited

GR91 - 01 April 2010 - 18:15-19:00 CET

Expert: Johanna Bendell, Sarah Cannon Research Institute, Nashville, TN, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details


Targeted therapies and radiotherapy in head and neck cancer CME accredited

GR90 - 25 March 2010 - 18:15-19:00 CET

Expert: Jacques Bernier, Clinic of Genolier, Genolier, Switzerland
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Head-and-neck cancer   Radiation oncology  

View details


The role of accelerated partial breast irradiation in the treatment of early-stage breast cancer (in co-operation with OECI) CME accredited

GR89 - 18 March 2010 - 18:15-19:00 CET

Expert: Csaba Polgar, National Institute of Oncology, Budapest, Hungary
Discussant: Roberto Orecchia, European Institute of Oncology, Milano, Italy
Topics: Breast cancer   Radiation oncology  

View details


Innovative techniques in radiation oncology applied to lung cancer (in co-operation with OECI) CME accredited

GR88 - 11 March 2010 - 18:15-19:00 CET

Expert: Nicolas Pourel, Institut Sainte-Catherine, Avignon, France
Discussant: Pierre Fournel, Saint-Etienne University Hospital, Saint-Etienne, France
Topics: Lung cancer   Radiation oncology  

View details


Early PET-CT adapted therapy in the management of Hodgkin lymphoma CME accredited

GR87 - 04 March 2010 - 18:15-19:00 CET

Expert: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: Haemato-oncology  

View details


Pitfalls and uncommon problems in thyroid cancer management CME accredited

GR84 - 11 February 2010 - 18:15-19:00 CET

Expert: Jean-Pierre Droz, Centre Leon-Berard, Lyon, France
Discussant: Christelle de la Fouchardière, Centre Leon-Berard, Lyon, France
Topics: Thyroid cancer  

View details


Gene profiling: From bench to bedside CME accredited

GR83 - 04 February 2010 - 18:15-19:00 CET

Expert: Laura van t Veer, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Discussant: Maria Grazia Daidone, IRCCS Foundation, National Cancer Institute, Milano, Italy
Topics: Breast cancer   General interest  

View details


The treatment of GIST tumors in 2010 CME accredited

GR80 - 14 January 2010 - 18:15-19:00 CET

Expert: Jean-Yves Blay, University Claude Bernard, Lyon, France
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details


Adjuvant therapy for rectal cancer CME accredited

GR79 - 17 December 2009 - 18:15-19:00 CET

Expert: Bruce D. Minsky, University of Chicago Medical Center, Chicago, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details


Breast cancer: Management of high risk women CME accredited

GR75 - 19 November 2009 - 18:15-19:00 CET

Expert: Banu Arun, MD Anderson Cancer Center, Houston, USA
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: Breast cancer  

View details


Is it time to consider MRI before prostate biopsy? (Review published in Nature Clinical Practice Oncology) CME accredited

GR73 - 05 November 2009 - 18:15-19:00 CET

Expert: Hashim Uddin Ahmed, University College London, Institute of Urology, London, United Kingdom
Discussant: Mark Emberton, University College London, Institute of Urology, London, United Kingdom
Topics: Genito-urinary cancers  

View details


Role of advocacy in the fight against breast cancer CME accredited

GR72 - 29 October 2009 - 18:15-19:00 CET

Expert: Stella Kyriakides, Europa Donna Cyprus, Nicosia, Cyprus
Discussant: Kathy Redmond, CancerWorld Editor, Lugano, Switzerland
Topics: Advocacy   Breast cancer  

View details


Neutropenia in cancer patients: Risk factors and management CME accredited

GR71 - 22 October 2009 - 18:15-19:00 CET

Expert: David C. Dale, University of Washington, Seattle, USA
Discussant: Jeffrey Crawford, Duke University Medical Center, Durham, NC, USA
Topics: Side effects   Supportive care  

View details


Indolent prostate cancer and active surveillance CME accredited

GR64 - 03 September 2009 - 18:15-19:00 CET

Expert: Chris Bangma, Erasmus Medical Centre, Rotterdam, The Netherlands
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Genito-urinary cancers  

View details


State-of-the-art and controversies in germ-cell cancer CME accredited

GR49 - 21 May 2009 - 18:15-19:00 CET

Expert: Roberto Salvioni, IRCCS Foundation, National Cancer Institute, Milano, Italy
Discussant: Andrea Necchi, IRCCS Foundation, National Cancer Institute, Milano, Italy
Discussant: Nicola Nicolai, IRCCS Foundation, National Cancer Institute, Milano, Italy
Topics: Genito-urinary cancers  

View details